Safety

La Crosse Method Reviewed

August 25, 2015

In recent years, sublingual immunotherapy has continued to gain acceptance and understanding, leading to its international recognition as a viable alternative to subcutaneous injection for allergy in both adults and children.1 With the recent FDA approval of single antigen sublingual immunotherapy tablets, even more physicians are considering, referring or offering sublingual immunotherapy for their patients.…

Read More